Cargando...

Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines

Recombinant thrombomodulin (rTM) has pleiotrophic properties, including anti‐coagulation and anti‐inflammation; however, its effectiveness as a treatment for multiple sclerosis (MS) has not been evaluated fully. High mobility group box 1 (HMGB1) and proinflammatory cytokines, working as inflammatory...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Exp Immunol
Autores principales: Uzawa, A., Mori, M., Masuda, H., Ohtani, R., Uchida, T., Kuwabara, S.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037993/
https://ncbi.nlm.nih.gov/pubmed/29509323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13123
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!